Answers are grounded in this paper and cite their sources.
BACKGROUND: Commonly used in vivo dosimeters often involve trade-offs between tissue equivalence and real-time readout capability. Organic thin film transistors (OTFTs) have emerged as a promising class of radiation dosimeters with the potential for tissue equivalence, mechanical flexibility, and real-time readout. PURPOSE: This study aims to assess the potential of OTFTs as real-time dosimeters for in vivo dosimetry through characterization under clinically relevant conditions. METHODS: OTFTs were characterized through dose linearity, dose rate dependence, and output factor measurements under reference conditions in solid water. OTFTs placed on the surface of an anthropomorphic phantom were then used to measure dose from a VMAT chest wall treatment plan delivered with and without bolus. The ability to measure out-of-field dose was also assessed using a VMAT breast treatment plan with the OTFT positioned on the contralateral side. OTFT measured doses were compared with Gafchromic EBT4 film and Eclipse treatment planning system (TPS) estimates. RESULTS: The OTFTs demonstrated excellent linearity with delivered dose over the investigated range and exhibited dose rate independence from 60 to 600 MU/min. Output factor measurements were within 1% of ionization chamber measurements for field sizes between 4 and 14 cm, while differences of 9.3% and 4.4% were observed for 2 and 3 cm fields, respectively. For VMAT phantom measurements without bolus, the OTFT was within 1% of film, while the TPS overestimated dose. With bolus, OTFT measurements were 8% lower than film and TPS measurements. A measurable response was observed under out-of-field conditions, although contributions from non-active detector components were substantial relative to the OTFT signal. CONCLUSIONS: OTFTs demonstrated desirable dosimetric characteristics under reference conditions and were capable of measuring dose during VMAT phantom treatments with results comparable to film. While additional optimization of the experimental setup and device sensitivity is required, the OTFTs exhibited promising initial performance for in vivo dosimetry applications.
No takes yet. Share an insight, caveat, or question.
Mitchell et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: